Date published: 2025-10-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

NAT-9 Inhibitors

NAT-9 inhibitors are a class of chemical compounds designed to target and inhibit the activity of NAT-9 (N-acetyltransferase 9), an enzyme involved in the acetylation of proteins or small molecules. NAT enzymes, including NAT-9, catalyze the transfer of an acetyl group from acetyl-CoA to an amine group on specific substrates. This post-translational modification plays a crucial role in regulating protein function, stability, and localization, as well as in modulating other cellular processes such as metabolism and gene expression. NAT-9 is thought to have a specific set of substrates or functions that contribute to cellular homeostasis, and its inhibition allows researchers to explore how the acetylation of these targets influences cellular pathways and dynamics.

The mechanism by which NAT-9 inhibitors function generally involves blocking the enzyme's active site, preventing the acetylation reaction from occurring. These inhibitors may bind to the acetyl-CoA binding site or the substrate recognition domain, either competitively or allosterically. Structurally, NAT-9 inhibitors are often designed to resemble the enzyme's natural substrates or transition states of the acetylation reaction, allowing them to bind with high affinity and specificity. By studying NAT-9 inhibitors, researchers can gain insights into the specific role of NAT-9 in acetylation-related processes and how this modification affects various biological functions. The inhibition of NAT-9 provides valuable information on the regulation of protein modification and its broader impact on cellular signaling, protein interaction networks, and metabolic control, offering a deeper understanding of how acetylation modulates critical aspects of cell biology.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$149.00
$470.00
$620.00
$1199.00
$2090.00
33
(3)

Trichostatin A could hyperacetylate histones near the NAT9 gene, leading to a tightly packed chromatin structure that may downregulate NAT9 transcription.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

By inhibiting the methylation of DNA, 5-Azacytidine may decrease the expression of NAT9 by disrupting transcription factor binding at its promoter region.

RG 108

48208-26-0sc-204235
sc-204235A
10 mg
50 mg
$128.00
$505.00
2
(1)

RG 108 may cause demethylation of the NAT9 promoter, reducing the recruitment of transcriptional machinery and thereby decreasing the expression of the NAT9 gene.

Mithramycin A

18378-89-7sc-200909
1 mg
$54.00
6
(1)

Mithramycin A could bind to the NAT9 gene's promoter, blocking the binding of essential transcription factors, leading to decreased levels of NAT9 mRNA.

Chloroquine

54-05-7sc-507304
250 mg
$68.00
2
(0)

Chloroquine may inhibit lysosomal degradation, which could lead to a buildup of cellular waste and subsequent downregulation of various genes, including NAT9.

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$73.00
$238.00
$717.00
$2522.00
$21420.00
53
(3)

Actinomycin D intercalates into DNA, which may inhibit RNA polymerase movement along the NAT9 gene, leading to a reduction in NAT9 mRNA synthesis.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

Rapamycin may lead to a reduced global protein synthesis rate, which could include a reduction in the translation of NAT9 mRNA into its protein product.

α-Amanitin

23109-05-9sc-202440
sc-202440A
1 mg
5 mg
$260.00
$1029.00
26
(2)

α-Amanitin could directly inhibit RNA polymerase II, resulting in a targeted decrease in the transcription of the NAT9 gene.

5-Aza-2′-Deoxycytidine

2353-33-5sc-202424
sc-202424A
sc-202424B
25 mg
100 mg
250 mg
$214.00
$316.00
$418.00
7
(1)

5-Aza-2′-Deoxycytidine may lead to the suppression of NAT9 expression by decreasing the methylation levels of its promoter, thereby reducing its transcription.

Disulfiram

97-77-8sc-205654
sc-205654A
50 g
100 g
$52.00
$87.00
7
(1)

Disulfiram may disrupt metalloenzyme function, potentially leading to a decrease in the enzymatic activity required for NAT9 gene transcription.